QUINTILES
Quintiles helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies. What drives us: the promise of medical breakthroughs that will improve and save lives. They invite you to explore the possibilities of partnering with Quintiles throughout the product lifecycle.
QUINTILES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1982-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.quintiles.com
Total Employee:
10001+
Status:
Active
Total Funding:
3.53 B USD
Technology used in webpage:
SPF SSL By Default Font Awesome Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 JsDelivr Microsoft Azure DNS
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Advisor
Board_member
Board_member
Current Employees Featured
John Leonard Board of Director @ Quintiles
Board of Director
Laurence Perreault Levasseur Senior Director @ Quintiles
Senior Director
Margaret Keegan President, Data Sciences, Safety and Regulatory @ Quintiles
President, Data Sciences, Safety and Regulatory
Slawek Wojtowicz Senior Medical Director @ Quintiles
Senior Medical Director
2014-05-01
Ross Horsburgh Senior Vice President, Deputy Head, Asia Pacific @ Quintiles
Senior Vice President, Deputy Head, Asia Pacific
Brian Kelly President, Payer & Provider Solutions @ Quintiles
President, Payer & Provider Solutions
Alejandro Martinez Chief Information Officer @ Quintiles
Chief Information Officer
Andrea Spannheimer Global Head, Real-World & Late Phase Research @ Quintiles
Global Head, Real-World & Late Phase Research
Jeffrey Spaeder Chief Medical and Scientific Officer @ Quintiles
Chief Medical and Scientific Officer
Elgar Peerschke President, Advisory Services @ Quintiles
President, Advisory Services
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-07-01 | Encore Health Resources | Encore Health Resources acquired by Quintiles | N/A |
| 2013-09-16 | Novella | Novella acquired by Quintiles | N/A |
| 2012-08-13 | Expression Analysis | Expression Analysis acquired by Quintiles | N/A |
| 2011-10-26 | Advion Inc. | Advion Inc. acquired by Quintiles | N/A |
| 2011-10-19 | VCG & Associates | VCG & Associates acquired by Quintiles | N/A |
| 2011-10-19 | Outcome Sciences | Outcome Sciences acquired by Quintiles | N/A |
| 2008-12-01 | Targeted Molecular Diagnostics | Targeted Molecular Diagnostics acquired by Quintiles | N/A |
| 2008-05-07 | Eidetics | Eidetics acquired by Quintiles | N/A |
| 2007-10-30 | Bio-Trials | Bio-Trials acquired by Quintiles | N/A |
| 2002-10-29 | Health Research Solutions | Health Research Solutions acquired by Quintiles | N/A |
Investors List
3i Group
3i Group investment in Private Equity Round - Quintiles
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2006-04-11 | Bayhill Therapeutics | Quintiles investment in Venture Round - Bayhill Therapeutics | 15.8 M USD |
| 2005-05-04 | Bayhill Therapeutics | Quintiles investment in Series B - Bayhill Therapeutics | 35.4 M USD |
| 2001-10-16 | D Pharm LTD. | Quintiles investment in Series D - D Pharm LTD. | 30 M USD |
| 2001-06-13 | NitroMed | Quintiles investment in Series E - NitroMed | 31.4 M USD |
Newest Events participated
Participated in Early Clinical Development 2017
on 2017-11-28 as sponsor
Participated in Partnerships in Clinical Trials Europe 2017
on 2017-11-28 as sponsor
Official Site Inspections
http://www.quintiles.com Semrush global rank: 60.29 K Semrush visits lastest month: 1.92 M
- Host name: 162.44.221.155
- IP address: 162.44.221.155
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 